I am a
Home I AM A Search Login

Papers of the Week

Papers: 1 Jun 2024 - 7 Jun 2024

2024 May 30

Eur J Pharmacol


Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis.


Fernández-Bravo-Rodrigo J, Cavero-Redondo I, Lucerón-Lucas-Torres M, Martínez-García I, Flor-García A, Barreda-Hernández D, Pascual-Morena C


Migraine is a common and disabling primary headache disorder. Several drugs targeting calcitonin gene-related peptide (CGRP), such as erenumab (an anti-CGRP receptor mAb), have been developed recently. However, the real-world effects of erenumab are not well understood.